Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Manisah Patel
University of Colorado Denver, Department: Pharmacology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Aeolus Pharmaceuticals, Inc.
Equity Interest - Publicly traded entity (e.g., stock, stock option, or other ownership interest)
Patel is Consultant for Aeolus, Spouse is Consultant for Aeolus w/ Stock Options valued at (b)(4)
Neuroprotective effects of AEOL 10150 against organophosphate toxicity
Chemical warfare agents are an immense threat to both the civilian population and military personnel and there is an urgent need for rapid development of medical countermeasures against chemical warfare agents. In particular, there is a dire need for neuroprotective therapies to counteract the central nervous system effects of chemical warfare agents. The goal of this project is to determine if catalytic antioxidant compound is a neuroprotective medical countermeasure against a class of chemical threat agents.
Filed on May 10, 2017.
Tell us what you know about Manisah Patel's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Manisah Patel”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Manisah Patel | University of Colorado Denver | Conflict of Interest | Aeolus Pharmaceuticals, Inc. | $40,000 - $59,999 |
| Manisah Patel | University of Colorado Denver | Conflict of Interest | Aeolus Pharmaceuticals, Inc. | $100,000 - $149,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.